Search
Viral Vectors
DNA
Antibiotic-free Maintenance System (ORT®)
Microbiota
Technical Protein
Fill Finish
Search
About
Events
Our Commitment to You
Our Mission & Values
Code of Conduct
Project Management
Quality Assurance
Our History
Sustainability
Careers
News
Contact Us
Select Language
Español
Deutsch
한국의
Français
Svenska
中国的
日本の
Menu
News
Discover the latest news stories, blog posts and publications from Cobra's expert team
Home
/
News
Toggle filters
Posts by Tag
August 2020
(5)
November 2017
(4)
April 2020
(4)
May 2013
(3)
October 2013
(3)
April 2017
(3)
July 2017
(3)
January 2018
(3)
November 2019
(3)
March 2020
(3)
October 2020
(3)
February 2021
(3)
June 2011
(2)
October 2011
(2)
February 2012
(2)
June 2012
(2)
October 2012
(2)
March 2013
(2)
February 2014
(2)
March 2014
(2)
June 2014
(2)
February 2015
(2)
September 2015
(2)
June 2016
(2)
November 2016
(2)
January 2017
(2)
December 2017
(2)
February 2018
(2)
March 2018
(2)
September 2018
(2)
October 2019
(2)
January 2021
(2)
January 2011
(1)
February 2011
(1)
July 2011
(1)
September 2012
(1)
November 2012
(1)
January 2013
(1)
June 2013
(1)
August 2013
(1)
December 2013
(1)
January 2014
(1)
April 2014
(1)
May 2014
(1)
September 2014
(1)
December 2014
(1)
March 2015
(1)
April 2015
(1)
May 2015
(1)
July 2015
(1)
August 2015
(1)
November 2015
(1)
February 2016
(1)
March 2016
(1)
May 2016
(1)
July 2016
(1)
October 2016
(1)
March 2017
(1)
May 2017
(1)
September 2017
(1)
October 2017
(1)
April 2018
(1)
May 2018
(1)
June 2018
(1)
October 2018
(1)
November 2018
(1)
January 2019
(1)
June 2019
(1)
September 2019
(1)
January 2020
(1)
June 2020
(1)
September 2020
(1)
December 2020
(1)
March 2021
(1)
See all
or
Posts by Tag
Gene Therapy
(24)
General
(22)
DNA
(18)
blog
(16)
Viral Vectors
(14)
vaccine
(13)
COVID-19
(11)
Awards
(9)
Coronavirus
(9)
Collaboration
(8)
Manufacturing
(8)
cell therapy
(8)
expansion
(8)
business
(7)
gene
(7)
therapy
(7)
award
(6)
international trade
(6)
AAV
(5)
CombiGene
(5)
immunotherapy
(5)
investment
(5)
plasmid dna
(5)
Cobra Biologics
(4)
Cognate BioServices
(4)
Innovate UK
(4)
News
(4)
Proteins
(4)
STEM
(4)
University
(4)
acquisition
(4)
development
(4)
#21Cmed
(3)
Advanced Therapy Medicinal Product
(3)
Alligator
(3)
Bionow
(3)
CG01
(3)
CMO
(3)
CPI
(3)
Featured
(3)
Innovate
(3)
adeno-associated virus
(3)
cell
(3)
clinical trials
(3)
epilepsy
(3)
export
(3)
grant
(3)
jobs
(3)
maxXpress
(3)
process
(3)
viral
(3)
A-level choices
(2)
ATMP
(2)
Advanced Therapies Manufacturing Taskforce
(2)
Careers in Science
(2)
Centre for Process Innovation
(2)
Charles River
(2)
Expertise
(2)
Finalists
(2)
GCSE options
(2)
GE Healthcare
(2)
GMP
(2)
Immune-oncology
(2)
Immuno-Oncology
(2)
Industrial Strategy
(2)
Manchester
(2)
Pharma
(2)
Quality
(2)
Queen's Award
(2)
Staffordshire
(2)
Trade
(2)
UK medicine
(2)
antibody
(2)
articles
(2)
bacteria
(2)
biologics
(2)
biopharmaceuticals
(2)
branding
(2)
cell line development
(2)
clinical
(2)
competition
(2)
education
(2)
expression
(2)
interview
(2)
medicine
(2)
microbioreactor
(2)
oxford
(2)
peer reviewed
(2)
plasmid
(2)
regenerative
(2)
science
(2)
single-use
(2)
vector
(2)
vectors
(2)
viral vector
(2)
vlog
(2)
ADC-1013
(1)
ADCs
(1)
ATAC
(1)
AstraZeneca
(1)
BioSpace
(1)
Bioscience
(1)
CAR-T
(1)
CDMO
(1)
CSO
(1)
Cancer
(1)
Capabilities
(1)
Capsules
(1)
Cell and Gene Therapy Catapult
(1)
Chambers
(1)
Cobra
(1)
Commerce
(1)
Compatibility
(1)
Director
(1)
Engineered
(1)
Future
(1)
Highlights
(1)
Innovation
(1)
Internal
(1)
Leukoencephalopathy
(1)
MHRA
(1)
Manufacturer
(1)
Multifocal
(1)
NEUWAY
(1)
Pall Corporation
(1)
ProFuse
(1)
Progressive
(1)
Puridify
(1)
Reliability
(1)
Sartorius
(1)
Sheffield
(1)
Staffs
(1)
Stedim
(1)
SwedenBIO
(1)
Symbiosis
(1)
Technologies
(1)
Tokyo
(1)
Tony Hitchcock
(1)
Touchlight
(1)
UCOE
(1)
UKTI
(1)
Viruses
(1)
Webinar
(1)
YEOTY
(1)
adenovirus
(1)
advanced
(1)
alevel choices
(1)
antibodies
(1)
apprenticeships
(1)
baculovirus
(1)
bioreactor
(1)
careers
(1)
cmo leadership award
(1)
commercial supply
(1)
compliance
(1)
costs
(1)
covid19
(1)
degree choices
(1)
department
(1)
disease
(1)
disposables
(1)
event
(1)
goals
(1)
growth
(1)
jenner institute
(1)
leadership
(1)
life
(1)
line
(1)
microbial
(1)
mobile
(1)
neurodegenerative
(1)
new website
(1)
of
(1)
operations
(1)
orphan
(1)
partnership
(1)
partnerships
(1)
processes
(1)
promising technologist
(1)
protein
(1)
rare
(1)
rare disease day
(1)
regulatory
(1)
relationship
(1)
responsive
(1)
risk
(1)
scancell
(1)
scientist
(1)
service
(1)
social media
(1)
solid
(1)
studies
(1)
study
(1)
supply
(1)
survey
(1)
technology
(1)
therapeutics
(1)
timelines
(1)
toxicity
(1)
trial
(1)
trials
(1)
tumours
(1)
visitor experience
(1)
web design
(1)
website
(1)
See all
INTERVIEW: Thomas Moore, Sky News, reports on the fight against COVID-19
vaccine
,
Coronavirus
,
COVID-19
Biologics manufacturing capacity and the challenges of scaling up vaccine production to fast track one million doses by September
Biologics manufacturing capacity and the challenges of scaling up vaccine production to fast track one million doses by September
INTERVIEW: Andrew Marr with Prof. Sarah Gilbert, vaccinologist at Oxford University
vaccine
,
Coronavirus
,
COVID-19
,
jenner institute
,
oxford
Cobra is proud to be part of a consortium, led by the Jenner Institute, Oxford University to rapidly develop a COVID-19 vaccine
Cobra is proud to be part of a consortium, led by the Jenner Institute, Oxford University to rapidly develop a COVID-19 vaccine
BLOG: COVID-19 Vaccine Hopes and Hurdles
Viral Vectors
,
DNA
,
blog
,
vaccine
,
Coronavirus
,
COVID-19
Cobra has been fortunate to be given the opportunity to work with two novel vaccine candidates against COVID-19, utilising the company’s knowledge and experience in the production...
Cobra Biologics has been fortunate to be given the opportunity to work with two novel vaccine candidates against COVID-19, utilising the company’s knowledge and experience in the production of plasmid DNA and viral vaccines. This blog aims to give a short introduction into the different types of vaccines that are in use, including the platform approaches relating to these two candidates and to highlight some of the potential manufacturing and
Cobra Biologics successfully completes key milestone in CombiGene’s epilepsy project CG01 with delivery of first DNA plasmid
Gene Therapy
,
News
,
CombiGene
,
plasmid dna
Production method of plasmids developed and first plasmid produced for gene therapy drug candidate aimed at treating drug resistant focal epilepsy
Production method of plasmids developed and first plasmid produced for gene therapy drug candidate aimed at treating drug resistant focal epilepsy